Nonsense-mediated decay: Linking a basic cellular process to human disease

Expert Review of Molecular Diagnostics

Volumn 9, Issue 4, 2009, Pages 299-303

  Bashyam, Murali D ^a  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; POLYADENYLIC ACID;

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; EDITORIAL; GENE MUTATION; HUMAN; NONHUMAN; NONSENSE MEDIATED DECAY; PREMATURE STOP CODON; RNA DEGRADATION; RNA SYNTHESIS; RNA TRANSLATION; STOP CODON; TRANSLATION REGULATION;

ANIMALS; CODON, NONSENSE; GENETIC DISEASES, INBORN; HUMANS; INTRONS; MAMMALS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TERMINATOR REGIONS, GENETIC;

EID: 66449089588     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.09.18     Document Type: Editorial

References (40)

1. Culbertson MR. RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer. Trends Genet. 15(2), 74-80 (1999). (Pubitemid 129749886)
2. Carter MS, Li S, Wilkinson MF. A splicing-dependent regulatory mechanism that detects translation signals. EMBO J. 15(21), 5965-5975 (1996). (Pubitemid 26375518)
3. Maquat LE, Li X. Mammalian heat shock p70 and histone H4 transcripts, which derive from naturally intronless genes, are immune to nonsense-mediated decay. RNA 7(3), 445-456 (2001). (Pubitemid 32381918)
4. Le Hir H, Izaurralde E, Maquat LE, Moore MJ. The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J. 19(24), 6860-6869 (2000). (Pubitemid 32011679)
5. Buhler M, Steiner S, Mohn F, Paillusson A, Mühlemann O. EJC-independent degradation of nonsense immunoglobulin-μ mRNA depends on 3′ UTR length. Nat. Struct. Mol. Biol. 13(5), 462-464 (2006). (Pubitemid 43881589)
6. Rajavel KS, Neufeld EF. Nonsense-mediated decay of human HEXA mRNA. Mol. Cell Biol. 21(16), 5512-5519 (2001). (Pubitemid 32702455)
7. LeBlanc JJ, Beemon KL. Unspliced Rous sarcoma virus genomic RNAs are translated and subjected to nonsense-mediated mRNA decay before packaging. J. Virol. 78(10), 5139-5146 (2004). (Pubitemid 38581466)
8. Singh G, Rebbapragada I, Lykke-Andersen J. A competition between stimulators and antagonists of Upf complex recruitment governs human nonsense-mediated mRNA decay. PLoS Biol. 6(4), e111 (2008).
9. Brogna S, Wen J. Nonsense-mediated mRNA decay (NMD) mechanisms. Nat. Struct. Mol. Biol. 16(2), 107-113 (2009).
10. Shibuya T, Tange TØ, Sonenberg N, Moore MJ. eIF4AIII binds spliced mRNA in the exon junction complex and is essential for nonsense-mediated decay. Nat. Struct. Mol. Biol. 11(4), 346-351 (2004). (Pubitemid 38436799)
11. Tange TO, Nott A, Moore MJ. The ever-increasing complexities of the exon junction complex. Curr. Opin. Cell Biol. 16(3), 279-284 (2004). (Pubitemid 38610408)
12. Weng Y, Czaplinski K, Peltz SW. Genetic and biochemical characterization of mutations in the ATPase and helicase regions of the Upf1 protein. Mol. Cell Biol. 16(10), 5477-5490 (1996). (Pubitemid 26315068)
13. Bhattacharya A, Czaplinski K, Trifillis P, He F, Jacobson A, Peltz SW. Characterization of the biochemical properties of the human UPF1 gene product that is involved in nonsense-mediated mRNA decay. RNA 6(9), 1226-1235 (2000).
14. Kim YK, Furic L, Desgroseillers L, Maquat LE. Mammalian Staufen1 recruits Upf1 to specific mRNA 3′UTRs so as to elicit mRNA decay. Cell 120(2), 195-208 (2005). (Pubitemid 40174763)
15. Kaygun H, Marzluff WF. Regulated degradation of replication-dependent histone mRNAs requires both ATR and Upf1. Nat. Struct. Mol. Biol. 12(9), 794-800 (2005). (Pubitemid 43086254)
16. Medghalchi SM, Frischmeyer PA, Mendell JT, Kelly AG, Lawler AM, Dietz HC. Rent1, a trans-effector of nonsense-mediated mRNA decay, is essential for mammalian embryonic viability. Hum. Mol. Genet. 10(2), 99-105 (2001). (Pubitemid 32098119)
17. Azzalin CM, Lingner J. The human RNA surveillance factor UPF1 is required for S phase progression and genome stability. Curr. Biol. 16(4), 433-439 (2006). (Pubitemid 43259356)
18. Serin G, Gersappe A, Black JD, Aronoff R, Maquat LE. Identification and characterization of human orthologues to Saccharomyces cerevisiae Upf2 protein and Upf3 protein (Caenorhabditis elegans SMG-4). Mol. Cell Biol. 21(1), 209-223 (2001).
19. Kadlec J, Guilligay D, Ravelli RB, Cusack S. Crystal structure of the UPF2-interacting domain of nonsense-mediated mRNA decay factor UPF1. RNA 12(10), 1817-1824 (2006). (Pubitemid 44484255)
20. Kadlec J, Izaurralde E, Cusack S. The structural basis for the interaction between nonsense-mediated mRNA decay factors UPF2 and UPF3. Nat. Struct. Mol. Biol. 11(4), 330-337 (2004). (Pubitemid 38436797)
21. Gehring NH, Kunz JB, Neu-Yilik G et al. Exon-junction complex components specify distinct routes of nonsense-mediated mRNA decay with differential cofactor requirements. Mol. Cell 20(1), 65-75 (2005). (Pubitemid 41396563)
22. Wilkinson MF. The cycle of nonsense. Mol. Cell 12(5), 1059-1061 (2003). (Pubitemid 37487914)
23. Brumbaugh KM, Otterness DM, Geisen C et al. The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells. Mol. Cell 14(5), 585-598 (2004). (Pubitemid 38739082)
24. Chawla R, Azzalin CM. The telomeric transcriptome and SMG proteins at the crossroads. Cytogenet. Genome Res. 122(3-4), 194-201 (2008).
25. Anders KR, Grimson A, Anderson P. SMG-5, required for C. elegans nonsense-mediated mRNA decay, associates with SMG-2 and protein phosphatase 2A. EMBO J. 22(3), 641-650 (2003). (Pubitemid 36193608)
26. Unterholzner L, Izaurralde E. SMG7 acts as a molecular link between mRNA surveillance and mRNA decay. Mol. Cell 16(4), 587-596 (2004). (Pubitemid 39531881)
27. Huntzinger E, Kashima I, Fauser M, Saulière J, Izaurralde E. SMG6 is the catalytic endonuclease that cleaves mRNAs containing nonsense codons in metazoan. RNA 14(12), 2609-2617 (2008).
28. Cho H, Kim KM, Kim YK. Human proline-rich nuclear receptor coregulatory protein 2 mediates an interaction between mRNA surveillance machinery and decapping complex. Mol. Cell 33(1), 75-86 (2009).
29. Hall GW, Thein S. Nonsense codon mutations in the terminal exon of the β-globin gene are not associated with a reduction in β-mRNA accumulation: a mechanism for the phenotype of dominant β-thalassemia. Blood 83(8), 2031-2037 (1994). (Pubitemid 24112712)
30. Pusch M. Myotonia caused by mutations in the muscle chloride channel gene CLCN1. Hum. Mutat. 19(4), 423-434 (2002). (Pubitemid 34252324)
31. Anczukow O, Ware MD, Buisson M et al. Does the nonsense-mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins? Hum. Mutat. 29(1), 65-73 (2008).
32. Dietz HC, Mcintosh I, Sakai LY et al. Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics 17(2), 468-475 (1993). (Pubitemid 23231307)
33. Bashyam MD. Studies on nonsense mediated decay reveal novel therapeutic options for genetic diseases. Recent Pat. DNA Gene Seq. 3(1), 7-15 (2009).
34. Kerr TP, Sewry CA, Robb SA, Roberts RG. Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay? Hum. Genet. 109(4), 402-407 (2001). (Pubitemid 33064519)
35. Aartsma-Rus A, De Winter CL, Janson AA et al. Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons. Mol. Ther. 14(3), 401-407 (2006). (Pubitemid 44184959)
36. - channel. Cell 76(6), 1091-1098 (1994). (Pubitemid 24106388)
37. Kerem E. Pharmacologic therapy for stop mutations: how much CFTR activity is enough? Curr. Opin. Pulm. Med. 10(6), 547-552 (2004). (Pubitemid 39441452)
38. Wilschanski M, Yahav Y, Yaacov Y et al. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N. Engl. J. Med. 349(15), 1433-1441 (2003). (Pubitemid 37211058)
39. Kerem E, Hirawat S, Armoni S et al. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective Phase II trial. Lancet 372(9640), 719-727 (2008).
40. Sako Y, Usuki F, Suga H. A novel therapeutic approach for genetic diseases by introduction of suppressor tRNA. Nucleic Acids Symp. Ser. (Oxf.) 50, 239-240 (2006).